topSkip to main content

Menu, Secondary

Menu Trigger


Confronting COVID-19

Data collected about the effects of the COVID-19 pandemic on U.S. residents shows that 80% experienced some sort of hardship and that those hardships are not equally distributed across groups.
A new study by Keck School of Medicine (KSOM) researchers reveals how therapies targeting a molecular chaperone called GRP78 might offer additional protection against COVID-19 and other coronaviruses that emerge in the future.
The dean of Rutgers School of Public Health discusses what the near future of the pandemic looks like
An Ohio State study shows SARS-CoV-2 infection risk at the dentist’s office is low
Researchers at University of California San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.
The University of Illinois System has received emergency use authorization (EUA)  from the U.S. Food and Drug Administration (FDA) for covidSHIELD, its innovative saliva-based COVID-19 test that was used on the U of I campuses to hold the virus in check by utilizing widespread testing with rapid results.
At 10:25 a.m. Thursday, CU Boulder senior Olivia Parsons became the first participant to receive vaccination in a national study aimed at answering a critical question in the fight against COVID-19: Does the Moderna shot prevent people from spreading the virus?
Mariam Bonyadi Camacho, a student in the medical scholars program at the University of Illinois Urbana-Champaign, co-wrote a recent report on the coronavirus’ cardiac effects, both short- and long-term
The University at Buffalo has generously shared its expertise and resources to help Western New York respond to, and ultimately conquer, this deadly virus